Espinoza Octavio sold LGND
March 11, 2026 · Form 4 insider transaction
Espinoza Octavio sold 3,057 shares of Ligand Pharmaceuticals Incorporated at $225.00 per share, a transaction worth $687.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,057
Price
$225.00
Total value
$687.8K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 11, 2026
Filing dateMarch 13, 2026
Shares owned after21,010
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.